MC4R and myeloid sarcoma: Additionally, in vitro evidence of the anti-inflammatory effects of MC4R activation are mainly built on LPS-induced inflammatory responses, while the inflammatory microenvironment seen in MS lesions is associated with increased cytokine levels including tumor necrosis factor alpha (TNF-α), and interferon gamma (IFN-γ) (20, 21).